Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barry

Showing results (1061-1070 of 1,077) with videos related to

Pageof 108
Sort By:
Kidney International|August 24, 2025
Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infectionPeter P Reese, Sumit Mohan, Douglas E Schaubel, et al.
Surgical Oncology|January 22, 2026
The rate of non-sentinel lymph node metastases at axillary dissection in patients with a positive sentinel lymph node after neoadjuvant chemotherapyA M Zaborowski, F Wehrmann, J McGarry, et al.
Science Translational Medicine|September 25, 2024
B cells drive neuropathic pain-related behaviors in mice through IgG-Fc gamma receptor signalingMichael J Lacagnina, Kendal F Willcox, Nabila Boukelmoune, et al.
Annals of the American Thoracic Society|March 1, 2018
Tuberculosis Mortality in the United States: Epidemiology and Prevention OpportunitiesSuzanne F Beavers, Lisa Pascopella, Amy L Davidow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2016
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Kidney International|December 29, 2022
Pathological characteristics of light chain crystalline podocytopathySamih H Nasr, Satoru Kudose, Vincent Javaugue, et al.
Open Forum Infectious Diseases|May 22, 2026
Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in CaliforniaShereen S Katrak, Rebecca C Wang, Chris E Keh, et al.
Science Translational Medicine|January 3, 2020
Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarctionSujitha Thavapalachandran, Stuart M Grieve, Robert D Hume, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
Pageof 108

Showing results (1061-1070 of 1,077) with videos related to

Sort By:
Pageof 108
Kidney International|August 24, 2025
Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infectionPeter P Reese, Sumit Mohan, Douglas E Schaubel, et al.
Surgical Oncology|January 22, 2026
The rate of non-sentinel lymph node metastases at axillary dissection in patients with a positive sentinel lymph node after neoadjuvant chemotherapyA M Zaborowski, F Wehrmann, J McGarry, et al.
Science Translational Medicine|September 25, 2024
B cells drive neuropathic pain-related behaviors in mice through IgG-Fc gamma receptor signalingMichael J Lacagnina, Kendal F Willcox, Nabila Boukelmoune, et al.
Annals of the American Thoracic Society|March 1, 2018
Tuberculosis Mortality in the United States: Epidemiology and Prevention OpportunitiesSuzanne F Beavers, Lisa Pascopella, Amy L Davidow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2016
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Kidney International|December 29, 2022
Pathological characteristics of light chain crystalline podocytopathySamih H Nasr, Satoru Kudose, Vincent Javaugue, et al.
Open Forum Infectious Diseases|May 22, 2026
Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in CaliforniaShereen S Katrak, Rebecca C Wang, Chris E Keh, et al.
Science Translational Medicine|January 3, 2020
Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarctionSujitha Thavapalachandran, Stuart M Grieve, Robert D Hume, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
Pageof 108